Related Experiment Video
Updated: Jan 14, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient
Kaito Harada1,2, Shino Iwata2, Shinichiro Machida2
1Department of Hematology, Ebina General Hospital, Japan.
Insights
Chronic active Epstein-Barr virus infection (CAEBV) can affect the heart, leading to cardiomyopathy. Successful treatment involved chemotherapy and stem cell transplant, achieving long-term remission in a complex case.
Area of Science:
- Immunology
- Cardiology
- Virology
Background:
- Chronic active Epstein-Barr virus infection (CAEBV) is a rare, severe condition.
- CAEBV involves Epstein-Barr virus (EBV)-infected T or natural killer cells.
- Cardiac complications in CAEBV are uncommon but serious.
Purpose of the Study:
- To report a case of CAEBV with cardiomyopathy.
- To highlight diagnostic and therapeutic strategies.
- To emphasize long-term monitoring for cardiac involvement.
Main Methods:
- Diagnostic imaging and myocardial biopsy.
- High-dose cytarabine-based chemotherapy.
- Reduced-intensity conditioning cord blood transplantation.
Main Results:
- Diagnosis of EBV-positive T cell infiltration in the myocardium.
- Achieved complete donor chimerism post-transplant.
- Patient remained in remission for five years despite transient cardiac issues and EBV reactivation.
Conclusions:
- Myocardial biopsy is crucial for diagnosing cardiac involvement in CAEBV.
- Long-term monitoring is essential for CAEBV patients with cardiac complications.
- Multidisciplinary treatment approach can lead to successful outcomes.
Abstract:
Chronic active Epstein-Barr virus (CAEBV) infection is a rare and potentially fatal condition involving EBV-infected T or natural killer cells. We herein report a 46-year-old man with CAEBV complicated by cardiomyopathy. Imaging and a biopsy revealed EBV-positive CD3+ T cell infiltration in the myocardium. The patient was treated with high-dose cytarabine-based chemotherapy followed by cord blood transplantation using reduced-intensity conditioning, resulting in complete donor chimerism. Although transient cardiac dysfunction and post-transplant EBV reactivation occurred, the patient remained in remission for five years. This case underscores the importance of a myocardial biopsy and long-term monitoring of CAEBV with cardiac involvement.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Endocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

